Curcumin causes histone acetylation enhancement in Raji, HL-60 and K562 cell lines

Chinese Pharmacological Bulletin

Volumn 22, Issue 2, 2006, Pages 164-167

  Wang, Yan ^a   Hu, Jun Bin ^b   Chen, Yan ^b   Cui, Guo Hui ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acetylation; Curcumin; Deacetylation; Histone

Indexed keywords

CURCUMIN;

ACETYLATION; ARTICLE; BURKITT LYMPHOMA; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN K 562; CONTROLLED STUDY; DEACETYLATION; DOSE RESPONSE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MODULATION; RAJI CELL; SURVIVAL RATE;

EID: 33646241542     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cress WD, Seto E. Histone deacetylase transcription control, and cancer[J]. J Cell Physiol, 2000, 184(1):1-16.
2. Sasakawa Y, Naoe Y, Inoue T et al. Effects of FK228, a novel histone deaccetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo[J]. Biochem Pharmacol, 2002, 64(7):1079-90.
3. Richard L, Robey R, Sandor V et al. Inhibitors of histone deacetylation, Depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case in report[J]. Blood, 2001, 98:2865-8.
4. WAF1 involves changes in promoter-associated proteins, including HDAC1[J]. Proc Natl Acad Sci USA, 2004, 101(5):1241-6.
5. Han SS, Chung ST, Robertson DA et al. Curcumin causes the growth arrest apoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-xl, NF-κB and p53[J]. Clin Immunol, 1999, 93(2):152-61.
6. Aggarwal BB, Kumar A, Bharti AC et al. Anticancer potential of curcumin: preclinical and clinical studies[J]. Anticancer Res, 2003, 23(1A):363-98.
7. Finnin MS, Donigian JR, Cohen A et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors [J]. Nature. 1999, 401(6749):188-93.
8. Zhou Q, Melkoumian ZK, Lucktong A. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1[J]. J Biol Chem, 2000, 275(45):35256-63.
9. Liu HL, Chen Y, Cui GH, Zhou JF. Curcumin, a potent antitumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation[J]. Acta Pharmacol Sin, 2005, 26(5):603-9.